期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Liver injury induced by COVID 19 treatment–what do we know? 被引量:2
1
作者 Lekha Saha soumya vij Kajal Rawat 《World Journal of Gastroenterology》 SCIE CAS 2022年第45期6314-6327,共14页
The severity of coronavirus disease 2019(COVID-19)may be correlated with the risk of liver injury development.An increasing number of studies indicate that degrees of hepatotoxicity have been associated with using som... The severity of coronavirus disease 2019(COVID-19)may be correlated with the risk of liver injury development.An increasing number of studies indicate that degrees of hepatotoxicity have been associated with using some medications in the management of COVID-19 patients.However,limited studies have systematically investigated the evidence of drug-induced liver injury(DILI)in COVID-19 patients.An increasing number of studies indicate that degrees of hepatotoxicity have been associated with using some of these medications in the management of COVID-19 patients.Significantly,it was relieved after the cessation of these agents.However,to our knowledge,no studies have systematically investigated the evidence of DILI in COVID-19 patients.In this review,we discussed the association between hepatotoxicity in COVID-19 patients and the drugs used in these patients and possible mechanisms of hepatotoxicity.The currently available evidence on the association of different therapeutic agents with hepatotoxicity in COVID-19 patient was systematically reviewed. 展开更多
关键词 Liver injury COVID-19 Anti-COVID drugs MECHANISMS Clinical evidences
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部